Join usDonate


02 May 2024

ALN-APP study: who can participate and why?

We are getting closer to a drug study with ALN-APP and Dutchtype CAA in Perth. The so-called cAPPricorn-1 study will take place in 60 countries and start in Canada soon. Because the first participants with sporadic CAA will soon enroll, part of the protocol is placed online. Because this information is now public, we'd like to take the opportunity to inform you about choices that were made for the study about who can participate and why.

Read more

15 January 2024

What did Sanne do Down Under?

Read more

12 October 2023

Recording webinar August 10th- TRACK DCAA and the road towards a trial

Read more

12 August 2023

Alnylam: what you need to know

Read more

09 August 2023

Important new development: the 4 fases of Dutchtype CAA

Read more
More News